Literature DB >> 34529437

Investigation on Formulation Strategies to Mitigate Compression-Induced Destabilization in Supersaturated Celecoxib Amorphous Solid Dispersions.

Ka Rlis Be Rziņš1, Sara J Fraser-Miller1, Greg F Walker2, Thomas Rades3, Keith C Gordon1.   

Abstract

Compression-induced destabilization was investigated in various celecoxib amorphous solid dispersions containing hydroxypropyl methylcellulose (HPMC), poly(vinylpyrrolidone)/vinyl acetate copolymer (PVP/VA), or poly(vinylpyrrolidone) (PVP) at a concentration range of 1-10% w/w. Pharmaceutically relevant (125 MPa pressure with a minimal dwell time) and extreme (500 MPa pressure with a 60 s dwell time) compression conditions were applied to these systems, and the changes in their physical stability were monitored retrospectively (i.e., in the supercooled state) using dynamic differential scanning calorimetry (DSC) and low-frequency Raman (LFR) measurements over a broad temperature range (-90 to 200 and -150 to 140 °C, respectively). Both techniques revealed similar changes in the crystallization behavior between samples, where the application of a higher compression force of 500 MPa resulted in a more pronounced destabilization effect that was progressively mitigated with increasing polymer content. However, other aspects such as more favorable intermolecular interactions did not appear to have any effect on reducing this undesirable effect. Additionally, for the first time, LFR spectroscopy was used as a viable technique to determine the secondary or local glass-transition temperature, Tg,β, a major indicator of the physical stability of neat amorphous pharmaceutical systems.

Entities:  

Keywords:  amorphous drugs; celecoxib; compression-induced destabilization; differential scanning calorimetry; hydroxypropyl methylcellulose; low-frequency Raman spectroscopy; poly(vinylpyrrolidone); poly(vinylpyrrolidone)/vinyl acetate copolymer

Mesh:

Substances:

Year:  2021        PMID: 34529437     DOI: 10.1021/acs.molpharmaceut.1c00540

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  1 in total

1.  Low- versus Mid-frequency Raman Spectroscopy for in Situ Analysis of Crystallization in Slurries.

Authors:  Jaana Koskela; Joshua J Sutton; Tiina Lipiäinen; Keith C Gordon; Clare J Strachan; Sara J Fraser-Miller
Journal:  Mol Pharm       Date:  2022-05-03       Impact factor: 5.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.